PL2839836T3 - Probiotyki do zastosowania przy redukowaniu objawów choroby układu oddechowego - Google Patents

Probiotyki do zastosowania przy redukowaniu objawów choroby układu oddechowego

Info

Publication number
PL2839836T3
PL2839836T3 PL14186663T PL14186663T PL2839836T3 PL 2839836 T3 PL2839836 T3 PL 2839836T3 PL 14186663 T PL14186663 T PL 14186663T PL 14186663 T PL14186663 T PL 14186663T PL 2839836 T3 PL2839836 T3 PL 2839836T3
Authority
PL
Poland
Prior art keywords
probiotics
symptoms
reducing
respiratory disease
respiratory
Prior art date
Application number
PL14186663T
Other languages
English (en)
Other versions
PL2839836T5 (pl
Inventor
Gregory Leyer
Arthur Ouwehand
Original Assignee
Dupont Nutrition Biosciences Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39268947&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2839836(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dupont Nutrition Biosciences Aps filed Critical Dupont Nutrition Biosciences Aps
Publication of PL2839836T3 publication Critical patent/PL2839836T3/pl
Publication of PL2839836T5 publication Critical patent/PL2839836T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Otolaryngology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL14186663.2T 2006-10-02 2007-09-14 Probiotyki do zastosowania przy redukowaniu objawów choroby układu oddechowego PL2839836T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84866206P 2006-10-02 2006-10-02
EP07838266.0A EP2068899B1 (en) 2006-10-02 2007-09-14 Lactobacillus acidophilus for use in reducing the incidence and duration of respiratory infections
EP14186663.2A EP2839836B2 (en) 2006-10-02 2007-09-14 Probiotics for use in reducing symptoms of respiratory disease

Publications (2)

Publication Number Publication Date
PL2839836T3 true PL2839836T3 (pl) 2018-02-28
PL2839836T5 PL2839836T5 (pl) 2025-11-17

Family

ID=39268947

Family Applications (2)

Application Number Title Priority Date Filing Date
PL07838266T PL2068899T3 (pl) 2006-10-02 2007-09-14 Lactobacillus acidophilus do zastosowania w zmniejszaniu częstości występowania i czasu trwania zakażeń dróg oddechowych
PL14186663.2T PL2839836T5 (pl) 2006-10-02 2007-09-14 Probiotyki do zastosowania przy redukowaniu objawów choroby układu oddechowego

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL07838266T PL2068899T3 (pl) 2006-10-02 2007-09-14 Lactobacillus acidophilus do zastosowania w zmniejszaniu częstości występowania i czasu trwania zakażeń dróg oddechowych

Country Status (13)

Country Link
US (5) US20100040579A1 (pl)
EP (2) EP2068899B1 (pl)
JP (3) JP5896589B2 (pl)
KR (2) KR101485200B1 (pl)
CN (1) CN101528244B (pl)
AU (1) AU2007302715B2 (pl)
BR (1) BRPI0719787A2 (pl)
DK (2) DK2839836T4 (pl)
ES (2) ES2547480T3 (pl)
FI (1) FI2839836T4 (pl)
MX (1) MX2009003260A (pl)
PL (2) PL2068899T3 (pl)
WO (1) WO2008042101A2 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8492931B2 (en) 2009-12-02 2013-07-23 Kmw Inc. Selecting structure for device
JP5885287B2 (ja) * 2010-09-02 2016-03-15 アサヒカルピスウェルネス株式会社 インフルエンザの予防および／または治療剤
CN103220921B (zh) * 2010-10-15 2015-12-16 科.汉森有限公司 免疫佐剂
EP2455093A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections in children
EP2455092A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
EP3111942B1 (en) 2013-11-15 2021-01-06 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of urt infections in infants or young children at risk
CN104957260B (zh) * 2014-03-07 2018-07-24 内蒙古伊利实业集团股份有限公司 具有缓解咽喉部炎症功效的益生菌食品组合物及食品
CN107427054A (zh) 2015-03-05 2017-12-01 雀巢产品技术援助有限公司 用于预防或治疗婴儿或幼儿的耳炎或支气管炎的组合物
WO2020170981A1 (ja) 2019-02-21 2020-08-27 オリンパス株式会社 フローラ治療用処置具、内視鏡、フローラ治療法
WO2021062250A1 (en) 2019-09-25 2021-04-01 Tall Goods, Llc Methods for producing probiotics fortified avian eggs and egg products and formulations thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007A (en) * 1845-04-22 Improvement in separating tannin and coloring-matter in quercitron-bark
EP0951531B1 (en) * 1996-11-29 2007-02-28 Bio K + International Inc. Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof
JP4212838B2 (ja) * 2002-06-26 2009-01-21 カルピス株式会社 抗アレルギー剤
AU2003282494A1 (en) 2002-10-11 2004-05-04 Wyeth Nutritional formulations containing synbiotic substances
JP4850715B2 (ja) * 2003-12-17 2012-01-11 エヌ．ブイ．・ヌートリシア 乳酸産生菌及び肺機能
DE102004026706A1 (de) * 2004-05-28 2005-12-15 Merck Patent Gmbh Orale Darreichungsform enthaltend probiotische Bakterien
CA2470090A1 (fr) * 2004-06-18 2005-12-18 Bio-K Plus International Inc. Bacteries lactiques et leurs usages dans la prevention de diarrhee associee aux antibiotiques
US7862808B2 (en) † 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
ITMI20042189A1 (it) 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
ES2348403T3 (es) * 2005-02-15 2010-12-03 Barry R. Goldin Un alimento que contiene un probiotico y un beta-glucano aislado y metodos de uso del mismo.
US20070020249A1 (en) * 2005-04-29 2007-01-25 Downs Bernard W Compositions for prevention and treatement of symptoms of gastrointestinal distress
WO2007040446A1 (en) 2005-10-06 2007-04-12 Probi Ab Use of lactobacillus for treatment of autoimmune diseases

Also Published As

Publication number Publication date
DK2839836T3 (en) 2017-12-04
EP2839836B2 (en) 2024-06-26
JP5896589B2 (ja) 2016-03-30
KR20140002069A (ko) 2014-01-07
US20230256037A1 (en) 2023-08-17
AU2007302715B2 (en) 2013-01-31
JP2010505824A (ja) 2010-02-25
ES2547480T3 (es) 2015-10-06
EP2839836A1 (en) 2015-02-25
CN101528244B (zh) 2012-01-11
WO2008042101A3 (en) 2009-04-09
BRPI0719787A2 (pt) 2014-11-25
PL2839836T5 (pl) 2025-11-17
DK2839836T4 (da) 2024-08-26
PL2068899T3 (pl) 2015-12-31
US20140356329A1 (en) 2014-12-04
US20180000875A1 (en) 2018-01-04
JP2016128478A (ja) 2016-07-14
WO2008042101A2 (en) 2008-04-10
AU2007302715A1 (en) 2008-04-10
KR101485200B1 (ko) 2015-01-26
DK2068899T3 (da) 2015-09-28
EP2839836B1 (en) 2017-08-30
CN101528244A (zh) 2009-09-09
FI2839836T4 (fi) 2024-08-26
US20200316145A1 (en) 2020-10-08
MX2009003260A (es) 2009-05-11
JP2014058558A (ja) 2014-04-03
KR20090063222A (ko) 2009-06-17
US20100040579A1 (en) 2010-02-18
EP2068899A2 (en) 2009-06-17
ES2650375T3 (es) 2018-01-18
EP2068899B1 (en) 2015-07-01
KR101474188B1 (ko) 2014-12-17
ES2650375T5 (en) 2025-02-03

Similar Documents

Publication Publication Date Title
PL2839836T3 (pl) Probiotyki do zastosowania przy redukowaniu objawów choroby układu oddechowego
DK2077729T3 (da) Orale probiotiske doseringsformer
EP2032214A4 (en) NASAL LAYER DEVICES
PL3424932T3 (pl) Boronoftalidy do zastosowania terapeutycznego
EP2019911A4 (en) PULMONARMATRATZE
EP2025266A4 (en) CUSHION DEVICE
IL193604A (en) Use of human anti-22 @ il antibodies for @ preparation
BRPI0809866A2 (pt) "conjuntos multicamada"
PL2468290T3 (pl) Antagoniści aktywiny-ActRII do stosowania w leczeniu niedokrwistości
GB0625659D0 (en) Therapeutic compounds and their use
ZA200902419B (en) Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
IL182407A0 (en) Use of agomelating in obtaining medicaments intended for the treatment of generalized anxiety disorder
DE502008001632D1 (de) Karosserieaufbau
DE602007013317D1 (de) Inhalator
PL2056858T3 (pl) Leczenie stanów chorobowych płuc
IL199214A0 (en) New combination for use in the treatment of inflammatory disorders
BRPI0714318A2 (pt) Utilização de 2-benzoil-imidazopiridinas em terapêutica
EP2168955A4 (en) BED DRILLING MTTEL
DE602006000763D1 (de) Kissenkörper
BRPI0917541A2 (pt) utilização de soforicosida na fabricação de medicamentos
FR2903717B1 (fr) Marchepied amovible et autoverrouillable
GB0614538D0 (en) Therapeutic Compounds And Their Use
ES1066657Y (es) Almohada terapeutica
GB0603892D0 (en) Use of cobalamin and glutathionylcobalamin in the treatment of inflammatory disease
FI20060798A0 (fi) Vetoketjupatja